| 25 May 2026 |
Dianabol |
7.2 |
10mg |
9.6mg |
-3.6% |
98.58% |
Lab G |
| 25 May 2026 |
DSIP |
5.2 |
30mg |
31.4mg |
+4.5% |
96.14% |
Lab D |
| 25 May 2026 |
RIPEX 225 (TRA/Mast P/Test P) |
7.7 |
250mg/ml |
252.1mg/ml |
+0.9% |
95.01% |
Lab G |
| 24 May 2026 |
Ostarine (MK-2866) |
8.0 |
50mg |
51.7mg |
+3.4% |
95.97% |
Lab E |
| 24 May 2026 |
Tirzepatide |
9.8 |
10mg |
9.5mg |
-5.0% |
99.80% |
Lab G |
| 24 May 2026 |
Lipo-B 216mg |
8.8 |
300mg/ml |
261.3mg/ml |
-12.9% |
99.18% |
Lab F |
| 24 May 2026 |
MENT (Trestolone Acetate) |
8.9 |
100mg/ml |
109.6mg/ml |
+9.6% |
96.01% |
Lab F |
| 23 May 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
7.6 |
20mg |
17.3mg |
-13.3% |
99.79% |
Lab B |
| 23 May 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
4.0 |
10mg |
9.6mg |
-4.1% |
98.21% |
Lab D |
| 23 May 2026 |
Tesofensine |
9.6 |
10mg |
10.2mg |
+1.9% |
99.84% |
Lab A |
| 23 May 2026 |
Crystagen |
5.8 |
30mg |
27.7mg |
-7.6% |
99.04% |
Lab F |
| 23 May 2026 |
GW-501516 (Cardarine) |
8.8 |
25mg |
23.1mg |
-7.6% |
99.03% |
Lab E |
| 23 May 2026 |
Orforglipron |
4.6 |
25mg |
22.4mg |
-10.3% |
98.86% |
Lab B |
| 22 May 2026 |
Retatrutide |
6.6 |
30mg |
32.2mg |
+7.3% |
99.65% |
Lab E |
| 21 May 2026 |
Pancragen |
8.2 |
2mg |
2.0mg |
+0.5% |
96.88% |
Lab B |
| 21 May 2026 |
Supertest 450 |
7.2 |
100mg/ml |
111.7mg/ml |
+11.7% |
95.20% |
Lab G |
| 21 May 2026 |
Vilon |
6.7 |
20mg |
21.8mg |
+8.9% |
97.21% |
Lab F |
| 20 May 2026 |
Retatrutide |
8.0 |
10mg |
10.2mg |
+2.0% |
99.90% |
Lab E |
| 19 May 2026 |
Retatrutide |
7.0 |
10mg |
10.8mg |
+8.0% |
99.90% |
Lab E |
| 19 May 2026 |
Tirzepatide |
8.0 |
10mg |
10.1mg |
+1.0% |
99.90% |
Lab E |
| 19 May 2026 |
ACE-031 |
8.8 |
30mg |
30.7mg |
+2.4% |
95.93% |
Lab E |
| 19 May 2026 |
Retatrutide 5mg + Cagrilintide 5mg Blend |
7.3 |
2mg |
1.7mg |
-13.4% |
97.88% |
Lab E |
| 29 Jan 2026 |
KPV |
8.4 |
2mg |
2.1mg |
+4.4% |
95.21% |
Lab G |
| 26 Jan 2026 |
Tirzepatide |
5.4 |
30mg |
35.1mg |
+17.0% |
99.90% |
Lab G |
| 26 Jan 2026 |
Tirzepatide |
5.0 |
10mg |
11.8mg |
+18.0% |
99.80% |
Lab G |
| 19 Jan 2026 |
SS-31 |
8.1 |
50mg |
56.5mg |
+13.0% |
98.75% |
Lab F |
| 6 Jan 2026 |
Prostamax |
6.8 |
2mg |
1.9mg |
-5.3% |
97.00% |
Lab F |
| 5 Dec 2025 |
Adipotide |
6.2 |
30mg |
36.6mg |
+22.1% |
96.77% |
Lab A |
| 5 Dec 2025 |
Healthy Hair Skin Nails Blend (Niacinamide+Thiamine+Pantothenic Acid+Choline+Inositol+Niacin+Biotin+Folic Acid+Riboflavin) |
8.1 |
300mg/ml |
334.5mg/ml |
+11.5% |
95.46% |
Lab D |
| 17 Nov 2025 |
Abaloparatide |
6.0 |
15mg |
15.8mg |
+5.6% |
98.59% |
Lab C |
| 14 Nov 2025 |
AA Water |
10.0 |
20mg |
23.7mg |
+18.4% |
98.15% |
Lab G |
| 14 Nov 2025 |
Cortagen |
9.6 |
5mg |
5.5mg |
+9.7% |
98.76% |
Lab A |
| 14 Nov 2025 |
Halotestin (Fluoxymesterone) |
5.6 |
25mg |
21.7mg |
-13.1% |
95.97% |
Lab A |
| 14 Nov 2025 |
NAD+ |
4.9 |
10mg |
10.0mg |
+0.1% |
95.13% |
Lab F |
| 4 Nov 2025 |
Retatrutide 30mg Pen Kit |
7.3 |
20mg |
20.6mg |
+2.8% |
98.29% |
Lab D |
| 17 Oct 2025 |
Stanozolol (Winstrol) Raw |
7.7 |
1g |
0.9g |
-8.0% |
97.82% |
Lab A |
| 3 Oct 2025 |
1-Benzyl-4-piperidone CAS 3612-20-2 |
5.7 |
10g |
12.3g |
+22.5% |
97.10% |
Lab E |
| 3 Oct 2025 |
HCG |
6.4 |
5mg |
5.9mg |
+17.7% |
95.19% |
Lab A |